Investors often chase big names trading above $100 a share, but the best opportunities can come from smaller, overlooked companies priced under $10. Many of these are in growth sectors with improving fundamentals and strong analyst backing. Below are three Buy-rated stocks under $10 that combine upside potential with solid execution.
1. Payoneer Global (PAYO)
Price: ≈ $5.37 Consensus: Strong Buy Target: ≈ $9.00 (+67%)
Payoneer runs a global payments platform for small and midsize businesses, freelancers, and marketplaces. It enables cross-border transactions in 190 countries, making it a key player in digital commerce.
Why Analysts Like It:
• Q3 revenue $270.9 million (+17% YoY) beat expectations.
• Management raised 2025 guidance to $1.05–$1.07 billion revenue and $270–$275 million adjusted EBITDA.
• Expanding margins as cross-border volume scales.
Risks: Margin compression and increased fintech competition.
Bottom Line: Undervalued fintech exposure with profitable growth ahead.
2. Ardelyx (ARDX)
Price: ≈ $5.59 Consensus: Strong Buy Target: ≈ $11.50 (+100%)
Ardelyx develops therapies for gastrointestinal and kidney diseases. Its flagship product, IBSRELA, is driving record growth, with new launches expanding the addressable market.
Why Analysts Like It:
• Q3 product revenue $105.5 million; IBSRELA sales +92% YoY.
• Raised 2025 guidance to $270–$275 million IBSRELA sales.
• Pipeline includes XPHOZAH for CKD patients, adding a second growth engine.
Risks: Biotech volatility, payer dynamics, and regulatory updates.
Bottom Line: A profitable biotech under $10 with high-growth momentum.
3. Grab Holdings (GRAB)
Price: ≈ $5.56 Consensus: Buy Target: ≈ $6.16–$7.00 (+10–30%)
Grab is Southeast Asia’s “super-app,” combining ride-hailing, food delivery, and fintech in one ecosystem.
Why Analysts Like It:
• Q3 revenue $873 million (+14% YoY) beat forecasts.
• Full-year adjusted EBITDA raised to $490–$500 million.
• User engagement and delivery volumes continue to grow.
Risks: Intense competition and currency volatility in SEA markets.
Bottom Line: A steady regional play with profitability tailwinds.